InvestorsHub Logo

elllk

04/22/21 3:48 PM

#38751 RE: ratna1 #38745

I have seen many comments on Amarin and Vascepa but hadn't looked closely at it.

Certainly, in the long run, if good results continue, it will benefit from relationships with Harvard and Kaiser Permanente.